scPharmaceuticals Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
16.40
|
|
Average Rating
|
4.60
|
|
# Strong Buys
|
3
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.38
|
-0.37
|
0.01
|
2.63%
|
|
2022-06-30
|
-0.30
|
-0.35
|
-0.05
|
-16.67%
|
|
2022-03-31
|
-0.31
|
-0.28
|
0.03
|
9.68%
|
|
2021-12-31
|
-0.34
|
-0.27
|
0.07
|
20.59%
|
|
2021-09-30
|
-0.31
|
-0.24
|
0.07
|
22.58%
|
|
2021-06-30
|
-0.30
|
-0.26
|
0.04
|
13.33%
|
|
2021-03-31
|
-0.30
|
-0.26
|
0.04
|
13.33%
|
|
2020-12-31
|
-0.36
|
-0.28
|
0.08
|
22.22%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.00
|
|
2021-12-31
|
-1.03
|
|
2020-12-31
|
-1.32
|
|
2019-12-31
|
-1.77
|
|
2018-12-31
|
-1.58
|
|
2017-12-31
|
-1.73
|